Study Objectives: Objective sleep impairments in insomnia disorder (ID) are insufficiently understood. The present study evaluated whether whole-night sleep stage dynamics derived from polysomnography (PSG) differ between people with ID and matched controls and whether sleep stage dynamic features discriminate them better than conventional sleep parameters. Methods: Eighty-eight participants aged 21-70 years, including 46 with ID and 42 age-and sex-matched controls without sleep complaints, were recruited through www.sleepregistry.nl and completed two nights of laboratory PSG. Data of 100 people with ID and 100 age-and sex-matched controls from a previously reported study were used to validate the generalizability of findings. The second night was used to obtain, in addition to conventional sleep parameters, probabilities of transitions between stages and bout duration distributions of each stage. Group differences were evaluated with nonparametric tests. Results: People with ID showed higher empirical probabilities to transition from stage N2 to the lighter sleep stage N1 or wakefulness and a faster decaying stage N2 bout survival function. The increased transition probability from stage N2 to stage N1 discriminated people with ID better than any of their deviations in conventional sleep parameters, including less total sleep time, less sleep efficiency, more stage N1, and more wake after sleep onset. Moreover, adding this transition probability significantly improved the discriminating power of a multiple logistic regression model based on conventional sleep parameters. Conclusions: Quantification of sleep stage dynamics revealed a particular vulnerability of stage N2 in insomnia. The feature characterizes insomnia better than-and independently of-any conventional sleep parameter.
INTRODUCTION
Insomnia disorder (ID) is defined as a persistent complaint of difficulty initiating sleep, difficulty maintaining sleep, or early morning awakening, which subjectively impacts daytime functioning, occurs at least three times a week for a minimum of 3 months, and cannot be attributed directly to other coexisting medical conditions or to environmental or time constraints on sleep. 1 Current clinical or research diagnostic criteria for ID are based solely on subjective reports. [2] [3] [4] Although different dysregulated patterns of objective, polysomnographically assessed sleep have been hypothesized over the past decades to underlie the self-reported impairments, [5] [6] [7] [8] most polysomnography (PSG) studies could find only modest differences between people with ID and controls. 9, 10 According to a recent meta-analysis, 10 the most consistently observed PSG alterations in ID across studies are: shorter total sleep time (TST), longer sleep onset latency (SOL) and wake after sleep onset (WASO), lower sleep efficiency (SE), an increased number of awakenings (NWake), and a reduced amount of slow wave sleep (SWS). The duration of rapid eye movement (REM) sleep did not differ significantly between people with ID and controls, when the meta-analysis was performed on studies that used only self-reported criteria for participant selection. 10 These sleep parameters, however, do not fully utilize the information present in the polysomnogram and leave many important questions open. For example: Is the reduced time spent in SWS due to difficulties entering deep sleep or rather because SWS in ID is unstable and rapidly switches to lighter sleep or wakefulness? Several novel methodologies have recently been proposed to extract information about sleep dynamics. 11 Among those methods, analyses of the transition probabilities between sleep stages, and of the duration distributions of sleep and wake bouts, can be readily applied to scored PSG without much additional processing. Thus, findings from such analyses may be followed up relatively easily using data that are collected routinely in clinical practice and are available in existing databases. Furthermore, as several independent studies have demonstrated, [12] [13] [14] [15] [16] [17] indices of clinical relevance can be derived from these analyses in other sleep-related conditions such as sleep-disordered breathing, providing more sensitive measures of pathological sleep patterns and of responses to interventions than the conventional sleep parameters.
Statement of Significance
Systematic quantification of sleep stage dynamics in 46 patients with insomnia disorder and 42 controls without sleep complaints revealed a specific instability of stage N2 sleep in insomnia, making it difficult to reach stage N3. The characteristic discriminates people with insomnia from controls better than-and independently of-any conventional sleep parameter. Slow wave sleep, once reached, does not show this vulnerability. Generalizability of the finding could be demonstrated through validation in an independent sample. A focus on stage N2 vulnerability may accelerate progress in our understanding of the mechanisms underlying insomnia.
Whereas to the best of our knowledge, sleep stage dynamics have not previously been investigated in ID, two studies have reported on the overall dynamics between sleep and wakefulness. One study 18 showed that people with ID, in addition to having more frequent and longer nocturnal awakenings, wake from light sleep stages (non-REM sleep stages 1 and 2) significantly more often than healthy controls do. A recent study 19 with a larger sample size again showed prolonged awakenings and also reported significantly shorter uninterrupted sleep bouts in people with ID than in healthy controls. Whereas the focus of these studies was on overall sleep (dis)continuity, we considered that the bout durations of individual sleep stages, as well as the transition probabilities between the stages, could aid to determine the key features of disturbed sleep in ID. In the present study, we therefore systematically investigated the transition probabilities and bout durations across all stages and evaluated how well these features discriminate people with ID from matched controls (CTRL) without sleep complaints, relative to the conventional PSG summary measures.
METHODS

Participants
The study was approved by the ethics committee of the VU University Medical Center, Amsterdam, The Netherlands. Participants were recruited through advertisement and the Sleep Registry 20 and were screened by telephone followed by a face-toface structured interview with a sleep specialist (MSc in psychology and certified clinical psychologist, specialized in Cognitive Behavioral Therapy for Insomnia). Screening also included the Insomnia Severity Index (ISI). 21 All participants provided written informed consent. The inclusion criteria for the ID group (n = 46, age range 23-69 years) conformed to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, 2 International Classification of Sleep Disorders, Third Edition, 3 and Research Diagnostic Criteria 4 for Insomnia Disorder. The control group included age-and sex-matched volunteers (n = 42, age range 22-70 years) that reported to have no sleep difficulties during telephone screening and the face-to-face interview and were further confirmed by an ISI score less than 8. Exclusion criteria for all participants were: (1) diagnosed sleep apnea, restless legs syndrome, narcolepsy, or other somatic, neurological, or psychiatric disorders; (2) use of sleep medications within the last 2 months up to and including the recording days; (3) overt shifted or irregular sleep-wake rhythms, assessed using 1 week of actigraphy (Actiwatch AW4, Cambridge Neurotechnology Ltd., Cambridge, United Kingdom or GENEActiv Sleep, Activinsights Ltd., Kimbolton, United Kingdom) supplemented by sleep diaries. Additionally, data from participants showing signs of sleep apnea or restless legs during laboratory PSG assessments were excluded from analyses. Table 1 summarizes the demographic characteristics of the included participants and their self-reported sleep as assessed by the ISI and the 7-day sleep diary.
Protocol
People with ID and matched controls completed two consecutive nights of PSG in a laboratory setting. On the recording days, participants were asked to refrain from alcohol and drugs, as well as to limit consumption of caffeinated beverages to a maximum of two cups, which were allowed only before noon. PSG was performed using a 256-channel LTM HydroCel Geodesic Sensor Net and a Polygraphic Input Box (Electrical Geodesic Inc., Eugene, Oregon, United States), connected to a Net Amps 300 amplifier (input impedance: 200 MΩ, A/D converter: 24 bits). The lights-out time for each participant was adaptively chosen according to individual habitual bedtime and did not significantly differ between the two groups (mean ± standard deviation: ID = 23:27 ± 0:37, CTRL = 23:28 ± 0:45 hours, p = .69).
Scoring of Sleep Recordings
All sleep recordings were visually scored offline by an experienced scorer (JRR) blind to the participants' group classification. Interscorer agreement in our lab generally lies between 0.67 and 0.80 (mean = 0.72 and 0.76 for ID and CTRL, respectively) in terms of Cohen's kappa, that is, within the range of those reported in the literature. 22 23 The first night served as an adaption night, and data from the second night were used for analyses. 10 The operational definitions of these parameters adhered to standard clinical guidelines. 23, 24 In particular, sleep onset was defined as the first epoch of any sleep stage, including stage N1. Additionally, the stage shift index (SSI), defined as the number of transitions between distinct stages per hour, was quantified as an index of overall sleep fragmentation.
24,25
Sleep Stage Transition Probabilities
To quantify sleep stage dynamics, we assessed the empirical probabilities of transitions between the stages including wakefulness, as well as the group-level bout duration distributions for each stage. Sleep stage dynamics were analyzed for the period between sleep onset and the final awakening.
The (Markovian) transition probability, P ij , is defined for each pair of stages-including the "transition" from one stage to the same stage-as the conditional probability of an epoch being in one stage j, given the stage i of the immediately preceding epoch. Empirically, P ij can be estimated by the observed proportion of epochs of stage i that were immediately followed by an epoch of stage j (where i and j can be the same stage); that is, the number of epochs which were scored as stage j and immediately followed an epoch of stage i, divided by the total number of epochs scored as stage i. The empirical transition probabilities between all pairs of stages were calculated for each participant separately.
Sleep Stage Bout Duration Distributions
Group-level bout duration distributions, first for sleep and wakefulness and subsequently for each separate sleep stage, were assessed with survival-analytical techniques, similar to those carried out in previous studies on sleep-wake transition patterns. [26] [27] [28] [29] To first investigate overall sleep versus wake bouts as previously reported, we defined sleep bouts as consecutive epochs scored as stages N1, N2, N3, or R and wake bouts as consecutive epochs scored as stage W. Next, at a more fine-grained level, we extracted bouts of individual sleep stages, that is, consecutive epochs scored as the same sleep stage. For all bout categories (sleep, wake, individual sleep stages), nonparametric recurrent event survival analysis 30 was used to estimate the bout duration distribution of each group. This yielded the survival function which gives, for each observed duration, the probability that a bout spans longer than that duration, while taking into account the fact that multiple bouts were observed from each participant.
Statistical Analyses of Group Differences
Group differences in the conventional sleep parameters were evaluated with Wilcoxon rank-sum tests. The rank-sum statistic W (also known as the Mann-Whitney U statistic), is mathematically equal to the product of group sizes ( ) n n 1 2 times the area under the receiver operating characteristic curve. 31 Thus, the absolute deviation of W from 0 5 1 2 . n n provides a direct measure of the discriminating power of each parameter.
For empirical transition probabilities, no formal statistical tests were performed for rare stage transitions which occurred in fewer than half of the participants in each group (ie, in fewer than 23 people with insomnia and fewer than 21 controls). The remaining values in the transition probability matrices were compared between the two groups by means of element-wise Wilcoxon rank-sum tests. To account for multiple comparisons, we applied Benjamini-Hochberg false discovery rate (FDR) correction and report group differences at a significance level of corrected p < .05 and at a trend level of corrected p < .10.
For bout duration distributions, the within-group confidence intervals of the survival functions were estimated through a bootstrap approach. 32 Group differences in the survival probabilities were determined by means of permutation Mann-Whitney tests. 33 For both bootstrap and permutation, resampling was done over 10,000 randomization iterations at the participant level, so that the within-participants bout recurrence information was preserved in every iteration.
Evaluation of Discriminating Power of Conventional and Novel Features With Logistic Regression
Separate logistic regression analyses were used to estimate the odds ratio (OR) of having ID per unit change in each parameter that showed a significant group difference in the above betweengroup comparison, adjusted for age and sex. Regression coefficients ± two standard errors were exponentiated to obtain ORs and their 95% confidence intervals. The relative importance of each sleep parameter in ID-CTRL discrimination was further investigated using forward stepwise logistic regression. The procedure started with a model including only age and sex covariates and in a stepwise fashion added the independent variable that increased the model fit the most, until no feature could further increase the model fit significantly as assessed by chi-squared likelihood ratio tests.
To evaluate whether the novel sleep stage dynamic features added ID-CTRL discriminating power to the information available in all possible combinations of the conventional sleep parameters, we moreover performed a chi-squared likelihood ratio test comparing two nested multiple logistic regression models: One included as independent variables age, sex, and the conventional sleep parameters showing significant group differences, and the other in addition included the single best discriminating bout duration or transition probability feature. All logistic regression analyses were performed in R. 34 
Validation of Generalizability
Validation of generalizability was pursued using sleep stage data of 100 people with ID and 100 healthy controls from a published investigation 35 undertaken at the Freiburg University Medical Center, Freiburg, Germany. Both ID and CTRL groups consisted of 46 males and 54 females and the ages (mean ± standard deviation) were 42.6 ± 12.5 years for ID and 41.1 ± 14.0 years for CTRL. Thus, the mean age of the Freiburg sample was lower than that of the Amsterdam sample (Student t-tests: p = .002 and .03 for ID and CTRL, respectively), and the sex distribution was more balanced (Fisher exact tests: p = .001 and .01 for ID and CTRL, respectively). Details about the participants' conventional PSG sleep parameters were given in the previous publication. 35 For both samples, sleep stage data were obtained from the second night of a two-night protocol, and PSG scoring was both done in 30-second epochs. However, one major difference regarding sleep scoring was that the Freiburg data were scored based on the Rechtschaffen-Kales criteria, 36 while the Amsterdam data were scored according to the AASM manual. 23 Sleep stage data from the Freiburg validation sample were first automatically preprocessed by (1) merging stages 3 and 4 according to the Rechtschaffen-Kales criteria into a single stage to approximate stage N3 according to the AASM criteria; and (2) converting epochs scored as movement time according to the Rechtschaffen-Kales criteria either to stage W if the preceding epoch was scored as stage W or to the same stage as that of the following epoch otherwise, in accordance with the "major body movement" rules in the AASM manual. Thereafter, the conventional sleep parameters, empirical transition probabilities, and sleep stage bout durations were extracted using the same procedure as described above. Between-group comparisons of transition probabilities and logistic regression analyses as described above were repeated on the Freiburg data. Table 2 summarizes the means and standard deviations of all conventional PSG sleep parameters for cases and controls in the Amsterdam sample, as well as the Wilcoxon rank-sum statistics and corresponding significance of group differences. As compared to CTRL, people with ID had significantly less TST, lower SE, a higher NWake and SSI, more WASO and stage N1 (expressed in either minutes or percentages), and less stage N3 (expressed in minutes). Table 3 presents the means and standard deviations of the empirical transition probabilities for cases and controls in the Amsterdam sample. Wilcoxon rank-sum tests on the transition probabilities revealed that, as compared to CTRL, people suffering from ID had a significantly higher probability to transition from stage N2 to stage N1 (Wilcoxon W = 1408, Z = 3.70, p = .004, FDR corrected), and a trend-level higher probability to transition from stage N2 to stage W (Wilcoxon W = 1276.5, Z = 2.59, p = .096, FDR corrected). Figure 1 illustrates these differences on a Markovian state diagram. Figure 2 shows the estimated bout survival functions for sleep, wakefulness, and individual sleep stages in ID and CTRL along with their 90% bootstrap confidence intervals. Previously reported scaling behaviors of sleep and wake bouts 26,37 could be replicated in both groups: sleep bout survival curves appear almost linear on the semilogarithmic scale, whereas wake bout survival curves take convex shapes. However, the precise parametric form of the bout survival functions has been a subject of debate in the literature. 12, 15, 16, 26 Thus, in the current study, we avoided explicitly modeling the bout survival functions with parametric methods and instead tested the between-group differences in bout duration distributions without assumptions using nonparametric procedures. Permutation Mann-Whitney tests 33 revealed that, as compared to CTRL, people with ID exhibited a significantly faster decaying sleep bout survival function (p = .009) and a nonsignificantly slower decaying wake bout survival function (p = .07). When bouts of each sleep stage were examined, the between-group difference was significant with respect to the stage N2 bout survival function (p = .02) but not for the other stages (p = .24, p = .16, and p = .28 for stage N1, stage N3, and stage R, respectively). The rank-sum statistics in the above between-group analyses suggest that the transition probability from stage N2 to stage N1 had the largest discriminating power among all examined features, although that of the best discriminative conventional sleep parameter, stage N1 percentage, was only slightly lower. It is worth noting that the two features were only moderately correlated: A Spearman correlation coefficient of 0.58 indicates that about two-thirds of their variance was independent. The second and third columns of Table 4 list the age-and sex-adjusted ORs of having ID and the associated 95% confidence intervals obtained via logistic regression, along with the corresponding p values. A forward stepwise search with sequential chi-squared likelihood ratio tests, starting with age and sex covariates, selected the transition probability from stage N2 to stage N1 in the first step (χ (1) = 10.58, p = .001), and found no other sleep parameters which further increased the model fit significantly, thus affirming the relative importance of the transition probability from stage N2 to stage N1 over the other sleep parameters in ID-CTRL discrimination.
RESULTS
To formally evaluate the added value of quantifying whole-night sleep stage dynamics in addition to conventional sleep parameters for discriminating cases from controls, two nested multiple logistic regression models were compared using a chi-squared likelihood ratio test. The first model included as independent Bold font highlights significant and trend-level group differences after false discovery rate correction (see text for test statistics).
variables age, sex, and the conventional sleep parameters showing significant group differences; the second also included the transition probability from stage N2 to stage N1 as an additional independent variable. The second model fitted the data significantly better (χ 2 (1) = 5.48, p = .02), confirming that the transition probability from stage N2 to stage N1 indeed added discriminating power on top of the information available in all possible combinations of the conventional PSG sleep parameters.
The empirical transition probabilities and their comparisons between cases and controls in the Freiburg validation sample are detailed in the Supplementary Material. The two rightmost columns of Table 4 show the age-and sex-adjusted ORs of having ID in the Freiburg validation sample and the corresponding p values. Of note, all features show the same directions of increased/decreased odds across the Amsterdam and Freiburg samples. Differences between the samples are however observed regarding the magnitudes of the effects (and statistical significance). Considering conventional sleep parameters, reduction of stage R in people with ID was more pronounced in the Freiburg validation sample. Stage N1 duration and the SSI did not significantly discriminate between cases and controls in the Freiburg validation sample, whereas they did in the Amsterdam sample.
With respect to features describing sleep stage dynamics, the transition probabilities from stages W, R, and N2 to stage W significantly increased, and the transition probability from stage W to stage N1 significantly decreased, in cases as compared to controls in the Freiburg validation sample, signifying a tendency to wake from sleep and difficulty reinitiating sleep in people with ID. On the other hand, an increased transition probability from stage N2 to stage N1 and a shortened mean stage N2 bout duration also significantly discriminated cases from controls, thus confirming stage N2 vulnerability in ID which we found in the Amsterdam sample. Forward stepwise logistic regression carried out on the Freiburg validation data selected the transition probability from stage W to stage W in the first step (χ 2 (1) = 19.01, p = 1 × 10 -5 ), the transition probability from stage R to stage W in the second step (χ 2 (1) = 9.17, p = .002), the transition probability from stage N2 to stage N1 in the third step (χ 2 (1) = 6.86, p = .008), and found no other sleep parameters which further increased the model fit significantly. Therefore, the transition probability from stage N2 to stage N1 was consistently among the most important features in ID-CTRL discrimination across samples.
Finally, we also evaluated in the Freiburg validation sample whether the novel sleep stage dynamic features added discriminating power to the information available in all possible combinations of the conventional sleep parameters. We found that three transition probabilities significantly improved the model fit on top of age, sex, and the conventional sleep parameters showing significant group differences: from stage W to stage W (χ 2 (1) = 7.37, p = .007), from stage N2 to stage N1 (χ 2 (1) = 5.23, p = .02), and from stage W to stage N1 (χ 2 (1) = 4.51, p = .03). Intriguingly, the transition probability from stage R to stage W did not increase the model fit significantly on top of the conventional PSG sleep parameters (χ 2 (1) = 2.07, p = .15). In other words, despite the relative importance of the transition probability from stage R to stage W over any single conventional sleep parameter in discriminating cases from controls in the Freiburg sample as indicated by forward stepwise regression, its discriminating power could be compensated by combination of multiple conventional sleep parameters. 
DISCUSSION
The current study is, to our knowledge, the first to analyze and compare the whole-night sleep stage dynamics of people with ID and healthy controls. We found that people with ID have a higher probability for stage N2 bouts to terminate early and to transition from stage N2 to stage N1 or wakefulness. Notably, even though people with ID show less SWS, they do not show significantly altered survival probabilities of stage N3 bouts nor altered transition probabilities from stage N3. These findings indicate that people with ID have a relatively normal tendency to remain in stage N3, once they reach this stage. Finally, logistic regression analyses showed not only that people with ID are best distinguishable from healthy controls in terms of the transition probability from stage N2 to stage N1 but also that including this transition probability can significantly improve the goodness of fit of a discriminative model on top of the conventional PSG sleep parameters.
The main findings of the current study could be replicated in an independent validation sample, confirming their generalizability. There are however a few differences regarding sleep architecture between the samples. In particular, reduced REM sleep and an increased transition probability from stage R to stage W in ID were significant in the Freiburg validation sample but not in the Amsterdam sample. Moreover, the higher transition probability from stage N2 to stage N1 in ID stood out more prominently in the Amsterdam sample than in the Freiburg validation sample. The differences may involve the different PSG scoring criteria used for the two samples. In a study comparing the Rechtschaffen-Kales and AASM scoring criteria, 38 it was found that the most pronounced differences result from Rule 5.C1.b of the AASM manual, which states that stage N2 terminates upon arousals. This rule led to decreases in stage N2, increases in stage N1, and increases in the number of stage shifts, when the same sleep recordings were scored according to the AASM criteria as compared to the Rechtschaffen-Kales criteria. 38, 39 It is thus likely that the large effect size of the transition probability from stage N2 to stage N1 observed in the Amsterdam sample involves an elevated number of arousals in people with ID. 35, 40 Different scoring criteria have also been shown to affect the scoring of REM sleep in young people but not in old people. 38, 39 The effect of this difference on transition probabilities is uncertain, although we expect it would affect controls more than people with ID given the speculated similarity between ID and aging discussed below. The transition probability from stage R to stage W was indeed significantly smaller in the Freiburg validation sample than in the Amsterdam sample only for CTRL On the other hand, it is worth noting that the overall sleep patterns of people with ID reported here are comparable to previous findings about the aged population. A series of studies have shown that among normal sleepers without sleep complaints, aging is associated with more stage N1 and less SWS, 41, 42 shorter sleep bouts, 29, 43 as well as relatively unstable non-REM sleep 29, 42 especially during stage N2, 42 paralleling the current results about sleep patterns in ID. Aging, however, seems to involve a relative increase in the number of short over long wake periods 43 -resulting in a steeper decay of the wake bout survival function 29 -while we have here observed the opposite pattern in ID, albeit only at a trend level. Consistently, prolonged awakenings in people with ID have been reported in other studies. 6, 18, 19 It should nonetheless be noted that the faster decaying wake bout survival function in aged people was only observed when data from a forced desynchrony protocol were pooled; when only data from sleep episodes taking place at the habitual circadian phase were examined, the wake bout survival probabilities of older and younger people did not differ significantly. 29 Since the current protocol does not allow to discriminate possibly different contributions of circadian and homeostatic factors, future studies with more elaborate experimental protocols are needed to disentangle their influences on sleep stage dynamics in ID. The similarity between the sleep patterns in ID and those in aging has been noticed in an early study which reported similar cumulative duration of each sleep stage over the night in aged people and in people with ID and concluded that ID might represent "precocious senescence of sleep." 5 This similarity points to a possible overlap between the neural mechanisms underlying the deterioration of sleep quality associated with ID and aging, as confirmed by recent neuroimaging studies. In particular, deficits of the orbitofrontal cortex have been suggested to be involved in self-reported insomnia symptoms 44, 45 and in sleep fragmentation quantified by actigraphy in aged people. 46 The neural mechanisms of age-related changes in sleep patterns from the cellular level up to the systems level have been studied extensively 47 and may serve as "roadmaps" for future research on the neurophysiological underpinnings of ID.
Our findings with respect to the conventional sleep parameters are largely congruent with a recent meta-analysis of PSG studies on ID. 10 Both the meta-analysis and the current study found reduced TST, reduced SE, increased WASO, an increased NWake, and less SWS in people with ID as compared to controls. The meta-analysis also reported longer SOL in ID. We did not find such a difference; instead, we found significantly more stage N1 in people with ID. The original publication on the Freiburg validation sample 35 adopted a different definition of sleep onset (first epoch of stage N2) than that used in the current study and also reported no group difference in SOL. Further analyses confirmed that SOL did not differ between groups in either sample, regardless of the definition of sleep onset (results not shown). Finally, the meta-analysis suggested that REM sleep did not differ between controls and people with ID, when studies that selected participants with self-reported criteria only were considered. Consistently, in the current study, all of our inclusion criteria were based on self reports, and we did not find between-group differences in the amount or percentage of REM sleep (for the Amsterdam sample). REM sleep deficits were significant when the meta-analysis included also studies which selected participants with both self-reported and PSG criteria. 10 These studies were nevertheless likely to select patient groups representing only a specific phenotype of ID. 48 The current findings suggest that zooming in on the microstructure and phasic components of stage N2 (ie, spindles and K-complexes) may be particularly helpful in elucidating the brain mechanisms of ID. Although previous investigations into these transient components in ID have shown mixed results, [49] [50] [51] [52] these studies have limitations in that spindles or K-complexes were only scored in one electrode. Possible differences between people with ID and normal sleepers may lie in the topographical distributions of these microstructural events or in the cortical or subcortical responses to them. 53, 54 Alternatively, the mixed results in the literature may also involve heterogeneous subtypes within ID. 55 Interestingly, studies that report alterations in characteristics of spindles or K-complexes in ID during stage N2 usually report no impairments with respect to the conventional PSG sleep parameters, 51, 52 and vice versa. 49, 50 This suggests that macrostructural and microstructural parameters might provide complementary insights into ID subtypes. Subtyping ID and characterizing the sleep patterns associated with each subtype is a continuous endeavor of sleep medicine research and may be the key to the future development of effective, targeted treatments for the disorder. 55 In conclusion, whole-night sleep stage dynamics reveal a particular stage N2 vulnerability in ID. Quantification of this vulnerability can easily be done using regularly scored PSG recordings. Further investigations of the neurophysiological dynamics during stage N2 may potentially lead to sensitive biomarkers of insomnia susceptibility, severity, or treatment outcome.
